Amplicon details |
||
Amplicon: |
215 bp | |
1 ctcaccttgc tcctgccgag aaagtatcca tcatggctga tgcaatgcgg 51 cggctgcata cgcttgatcc ggctacctgc ccattcgacc accaagcgaa 101 acatcgcatc gagcgagcac gtactcggat ggaagccggt cttgtcgatc 151 aggatgatct ggacgaagag catcaggggc tcgcgccagc cgaactgttc 201 gccaggctca aggcg |
Record ID | Database | Record description | Record length | Taxon | Method | Amplicon size | Match details |
---|---|---|---|---|---|---|---|
LY716845.1 | emblrelpat | KR 1020190095088-A/5: BIOACTIVE SUB... | 6330 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LY718246.1 | emblrelpat | KR 1020190090359-A/16: MESENCHYMAL ... | 795 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
MO695143.1 | emblrelpat | Sequence 28 from patent US 10538786. | 795 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
MO740975.1 | emblrelpat | Sequence 1 from patent US 10543260. | 2999 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
LY803195.1 | emblrelpat | KR 1020200022970-A/9: Production me... | 795 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LY817721.1 | emblrelpat | KR 1020200005721-A/1: ENVELOPED VIR... | 6606 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LY820516.1 | emblrelpat | KR 1020200018345-A/30: NOVEL CRISPR... | 5311 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LY820517.1 | emblrelpat | KR 1020200018345-A/31: NOVEL CRISPR... | 4926 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LY820518.1 | emblrelpat | KR 1020200018345-A/32: NOVEL CRISPR... | 5267 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LY822234.1 | emblrelpat | KR 1020200018364-A/31: NOVEL CRISPR... | 4926 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LY822235.1 | emblrelpat | KR 1020200018364-A/32: NOVEL CRISPR... | 5267 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LY824500.1 | emblrelpat | KR 1020200005552-A/4: RECOMBINANT B... | 1722 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LY824502.1 | emblrelpat | KR 1020200005552-A/7: RECOMBINANT B... | 1722 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LY824504.1 | emblrelpat | KR 1020200005552-A/10: RECOMBINANT ... | 1722 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LY824522.1 | emblrelpat | KR 1020200005552-A/42: RECOMBINANT ... | 1722 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LY828024.1 | emblrelpat | KR 1020200015900-A/19: SELF-INACTIV... | 17680 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LY828025.1 | emblrelpat | KR 1020200015900-A/20: SELF-INACTIV... | 15678 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LY829668.1 | emblrelpat | KR 1020200006557-A/5: COMPOSITIONS ... | 800 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
LY829672.1 | emblrelpat | KR 1020200006557-A/10: COMPOSITIONS... | 2999 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
MO887443.1 | emblrelpat | Sequence 3 from patent US 10561719. | 9064 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
Related publications:
Petrillo, M., et al. “JRC GMO-Amplicons: A Collection of Nucleic Acid Sequences Related to Genetically Modified Organisms.” Database (Oxford), vol. 2015 bav101, 30 Sep. 2015, doi:10.1093/database/bav101.
Angers-Loustau, A., et al. “Using the EURL GMFF Online Bioinformatics Resources: A how-to Guide for Practical JRC GMO-Matrix and JRC GMO-Amplicons Case Uses.” European Commission, Ispra, JRC101853, 2016.